D.E. Shaw & Co’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,921
Closed -$128K 3519
2024
Q1
$128K Sell
3,921
-158
-4% -$5.18K ﹤0.01% 2802
2023
Q4
$109K Buy
+4,079
New +$109K ﹤0.01% 2762
2023
Q1
Sell
-643
Closed -$249K 3645
2022
Q4
$249K Sell
643
-615
-49% -$238K ﹤0.01% 2958
2022
Q3
$424K Buy
1,258
+657
+109% +$221K ﹤0.01% 2938
2022
Q2
$198K Sell
601
-953
-61% -$314K ﹤0.01% 3401
2022
Q1
$680K Buy
+1,554
New +$680K ﹤0.01% 3069
2021
Q4
Sell
-614
Closed -$341K 4271
2021
Q3
$341K Sell
614
-2,448
-80% -$1.36M ﹤0.01% 3007
2021
Q2
$1.57M Sell
3,062
-3,438
-53% -$1.77M ﹤0.01% 2243
2021
Q1
$5.08M Buy
6,500
+1,905
+41% +$1.49M ﹤0.01% 1344
2020
Q4
$2.5M Sell
4,595
-475
-9% -$259K ﹤0.01% 1640
2020
Q3
$2.32M Sell
5,070
-5,338
-51% -$2.45M ﹤0.01% 1570
2020
Q2
$6.41M Sell
10,408
-3,417
-25% -$2.1M 0.01% 1058
2020
Q1
$6.57M Buy
13,825
+6,854
+98% +$3.26M 0.01% 933
2019
Q4
$4.04M Buy
6,971
+3,340
+92% +$1.94M ﹤0.01% 1288
2019
Q3
$2.39M Buy
3,631
+2,419
+200% +$1.59M ﹤0.01% 1495
2019
Q2
$938K Buy
+1,212
New +$938K ﹤0.01% 1903
2018
Q4
Sell
-1,260
Closed -$1.09M 2776
2018
Q3
$1.09M Buy
+1,260
New +$1.09M ﹤0.01% 1803
2018
Q1
Sell
-287
Closed -$127K 2687
2017
Q4
$127K Sell
287
-61
-18% -$27K ﹤0.01% 2433
2017
Q3
$172K Sell
348
-211
-38% -$104K ﹤0.01% 2367
2017
Q2
$310K Sell
559
-144
-20% -$79.9K ﹤0.01% 2131
2017
Q1
$465K Sell
703
-390
-36% -$258K ﹤0.01% 2003
2016
Q4
$365K Buy
+1,093
New +$365K ﹤0.01% 2157
2016
Q3
Sell
-521
Closed -$90K 2689
2016
Q2
$90K Sell
521
-157
-23% -$27.1K ﹤0.01% 2454
2016
Q1
$152K Sell
678
-2,561
-79% -$574K ﹤0.01% 2432
2015
Q4
$1.97M Sell
3,239
-1,460
-31% -$886K ﹤0.01% 1414
2015
Q3
$2.42M Buy
4,699
+4,141
+742% +$2.13M ﹤0.01% 1285
2015
Q2
$244K Buy
558
+13
+2% +$5.69K ﹤0.01% 2401
2015
Q1
$197K Buy
545
+130
+31% +$47K ﹤0.01% 2377
2014
Q4
$149K Buy
+415
New +$149K ﹤0.01% 2372